{"transactions":[{"id":859036,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":58488,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":66006,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":58488},"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":859035,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":7518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date."}],"balance_after":7518,"derivative":{"exercise_price":13.3,"expiration_date":"2036-03-03","underlying":"Ordinary Shares","underlying_shares":7518},"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":859034,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":43246,"price":13.774,"value":595670.404,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $13.74 USD to $14.07 USD; the price reported above reflects the weighted average sale price."}],"balance_after":72832,"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":859033,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":5377,"price":13.3054,"value":71543.1358,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price."}],"balance_after":116078,"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":859032,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-05T16:31:19.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":45112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal  parts on the first, second and third  anniversary of the grant date, subject to the reporting person's continued employment through such dates."}],"balance_after":121455,"source":{"system":"sec-edgar","filing":"0002039078-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000005/primarydocument.xml","form_type":"4"}},{"id":868897,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:10:09.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":408,"price":13.493,"value":5505.144,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $13.3126 USD to $13.70 USD; the price reported above reflects the weighted average sale price."}],"balance_after":76343,"source":{"system":"sec-edgar","filing":"0002039078-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000004/primarydocument.xml","form_type":"4"}},{"id":868896,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-03T16:10:09.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":1555,"price":13.6638,"value":21247.209,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.45 USD to $13.97 USD; the price reported above reflects the weighted average sale price."}],"balance_after":76751,"source":{"system":"sec-edgar","filing":"0002039078-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000004/primarydocument.xml","form_type":"4"}},{"id":941243,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-12T17:30:38.000Z","date":"2026-01-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2133,"price":14.35,"value":30608.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":78306,"source":{"system":"sec-edgar","filing":"0002039078-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907826000002/primarydocument.xml","form_type":"4"}},{"id":1008419,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-04T16:09:58.000Z","date":"2025-11-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2949,"price":12.23,"value":36066.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":80439,"source":{"system":"sec-edgar","filing":"0002039078-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907825000004/primarydocument.xml","form_type":"4"}},{"id":1008418,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-11-04T16:09:58.000Z","date":"2025-11-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":168,"price":12.81,"value":2152.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1)."}],"balance_after":83388,"source":{"system":"sec-edgar","filing":"0002039078-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000203907825000004/primarydocument.xml","form_type":"4"}},{"id":1159623,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-05-05T16:17:51.000Z","date":"2025-05-03","kind":"sale","planned":false,"acquired":false,"shares":592,"price":17.9125,"value":10604.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.8550 USD to $17.9498 USD; the price reported above reflects the weighted average sale price."}],"balance_after":83556,"source":{"system":"sec-edgar","filing":"0001562180-25-003589","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025003589/primarydocument.xml","form_type":"4"}},{"id":1220090,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-03-06T16:40:23.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":81499,"price":18.19,"value":1482466.81,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates."}],"balance_after":81499,"derivative":{"exercise_price":18.19,"exercise_date":"2026-03-04","expiration_date":"2035-03-03","underlying":"Ordinary Shares","underlying_shares":81499},"source":{"system":"sec-edgar","filing":"0001562180-25-002157","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025002157/primarydocument.xml","form_type":"4"}},{"id":1220089,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-06T16:40:23.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":54975,"price":18.19,"value":999995.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":84148,"source":{"system":"sec-edgar","filing":"0001562180-25-002157","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025002157/primarydocument.xml","form_type":"4"}},{"id":1230182,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T16:16:29.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":250,"price":18.5363,"value":4634.075,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On the transaction date, the reporting person sold 250 shares in multiple trades at prices ranging from $18.02 to $18.9918.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29173,"source":{"system":"sec-edgar","filing":"0001562180-25-001974","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025001974/primarydocument.xml","form_type":"4"}},{"id":1236355,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:26:06.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":368,"price":18.2843,"value":6728.6224,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 28, 2025, the reporting person sold 368 shares in multiple trades at prices ranging from $18.175 to $18.765.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29423,"source":{"system":"sec-edgar","filing":"0001562180-25-001912","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025001912/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1236354,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:26:06.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":267,"price":20.549,"value":5486.583,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 27, 2025, the reporting person sold 267 shares in multiple trades at prices ranging from $20.41 to $20.85.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29791,"source":{"system":"sec-edgar","filing":"0001562180-25-001912","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025001912/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1236353,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T21:26:06.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":1379,"price":19.9219,"value":27472.3001,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2025, the reporting person sold 1,379 shares in multiple trades at prices ranging from $19.41 to $20.4033.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30058,"source":{"system":"sec-edgar","filing":"0001562180-25-001912","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025001912/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-03-03"}},{"id":1236352,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T16:26:03.000Z","date":"2025-02-28","kind":"sale","planned":false,"acquired":false,"shares":368,"price":18.2843,"value":6728.6224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On February 28, 2025, the reporting person sold 368 shares in multiple trades at prices ranging from $18.175 to $18.765. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29423,"source":{"system":"sec-edgar","filing":"0001562180-25-001831","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025001831/primarydocument.xml","form_type":"4"}},{"id":1236351,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T16:26:03.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":267,"price":20.549,"value":5486.583,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 27, 2025, the reporting person sold 267 shares in multiple trades at prices ranging from $20.41 to $20.85.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":29791,"source":{"system":"sec-edgar","filing":"0001562180-25-001831","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025001831/primarydocument.xml","form_type":"4"}},{"id":1236350,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-03T16:26:03.000Z","date":"2025-02-27","kind":"sale","planned":false,"acquired":false,"shares":1379,"price":19.9219,"value":27472.3001,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2025, the reporting person sold 1,379 shares in multiple trades at prices ranging from $19.41 to $20.4033.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30058,"source":{"system":"sec-edgar","filing":"0001562180-25-001831","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025001831/primarydocument.xml","form_type":"4"}},{"id":1302766,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-15T16:23:58.000Z","date":"2025-01-11","kind":"sale","planned":false,"acquired":false,"shares":2160,"price":26.8084,"value":57906.144,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $26.44 USD to $27.185 USD; the price reported above reflects the weighted average sale price."}],"balance_after":31437,"source":{"system":"sec-edgar","filing":"0001562180-25-000375","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218025000375/primarydocument.xml","form_type":"4"}},{"id":1374400,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-06T16:27:08.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":45620,"price":16.59,"value":756835.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to buy 45,620 ordinary shares will vest in equal installments on each of November 4, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates."}],"balance_after":45620,"derivative":{"exercise_price":16.59,"expiration_date":"2034-11-03","underlying":"Ordinary Shares","underlying_shares":45620},"source":{"system":"sec-edgar","filing":"0001562180-24-007567","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218024007567/primarydocument.xml","form_type":"4"}},{"id":1374399,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-06T16:27:08.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":30138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units that are scheduled to vest in equal  parts on November 4, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates."}],"balance_after":33597,"source":{"system":"sec-edgar","filing":"0001562180-24-007567","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218024007567/primarydocument.xml","form_type":"4"}},{"id":1374398,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-06T16:27:08.000Z","date":"2024-11-02","kind":"sale","planned":false,"acquired":false,"shares":44,"price":16.6858,"value":734.1752,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":3459,"source":{"system":"sec-edgar","filing":"0001562180-24-007567","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218024007567/primarydocument.xml","form_type":"4"}},{"id":1377318,"issuer":{"id":4494,"kind":"organization","name":"NovoCure Ltd"},"owners":[{"id":62608,"kind":"person","name":"Paravasthu Mukund","position":1,"cik":"0002039078","reported_name":"Paravasthu Mukund","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares","published_at":"2024-11-04T16:32:28.000Z","date":"2024-11-01","kind":"sale","planned":false,"acquired":false,"shares":160,"price":15.8776,"value":2540.416,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.80 USD to $15.94 USD; the price reported above reflects the weighted average sale price."}],"balance_after":3503,"source":{"system":"sec-edgar","filing":"0001562180-24-007515","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039078/000156218024007515/primarydocument.xml","form_type":"4"}}]}